The National Institute of General Medical Sciences (NIGMS) welcomes four new members to the NIH Pharmacogenetics Research Network and Knowledge Base. NIGMS has also extended the funding of one existing Network investigator after successful completion of a 1-year pilot project. Another NIH component, the National Heart, Lung, and Blood Institute (NHLBI), has funded three of the five new awards.
The nationwide research effort, established in April 2000, aims to understand how a person's genetic make-up determines the way a medicine works in his or her body. The interactive research network of investigators stores data in a shared information library, called PharmGKB ( www.pharmgkb.org), which is freely accessible to the scientific community. To protect participants' privacy, names and other identifying information are not stored in this library.
In addition to NIGMS, other NIH components funding the pharmacogenetics research network awards are the National Cancer Institute; NHLBI; the National Human Genome Research Institute; the National Institute of Environmental Health Sciences; and the National Library of Medicine.
Five new awards, totaling $10.6 million for the first year of funding, have been made to:
For more information on the NHLBI-funded awards, contact the NHLBI Communications Office at 301-496-4236.
This page last reviewed on
8/9/2018 5:43 PM
Connect With Us: